Metsera Inc. (MTSR) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance
4 weeks ago • Google News
Metsera, Inc. Common Stock (MTSR)
US$ 24.96-0.28%
Price Chart
Key Statistics
Market Cap
$ 4.12B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
464.25K
52W High
$ 47.40
52W Low
$ 12.30
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
30.5783
200-Day MA
27.4547
52 Week High
47.4
52 Week Low
12.3
About MTSR
Metsera, Inc., a clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases.
Employees
104
Headquarters
New York, NY
CEO
Dr. Clive A. Meanwell M.D., Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg